Since 1999, when Nipah virus was first identified in Malaysia, it has repeatedly emerged in south and southeast Asia, quietly exploiting ecological and social susceptibilities. The danger of Nipah ...

As today's researchers face a tectonic shift in the foundations of global health, it is instructive to consider another time when international health research had to be re-established on a new ...

The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...

Norovirus—the “winter vomiting bug”—is responsible for millions of cases of vomiting and diarrhea each year.

Respiratory syncytial virus (RSV) remains one of the most significant viral threats across age groups, contributing to substantial morbidity in infants, older adults, and those with underlying ...

Six years since COVID-19 was declared a pandemic, here’s a snapshot of preparedness at a time of global health funding cuts, policy shifts and the spread of misinformation.

New research from Prenzler Group says Island Pharmaceuticals offers a compelling investment opportunity ... Read More The post New research on Island Pharmaceuticals highlights a “Compelling ...

The audited financial statements for the year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K contain an audit opinion from the Company’s independent registered public ...

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against ...

Discover how CRISPR-based therapy could revolutionize HPAI treatment in poultry, offering farmers a lifesaving alternative to complete flock depopulation and preventing costly outbreaks.

An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...